Role of HCN4 channel in preventing ventricular arrhythmia

Kazuo Ueda1, Yuji Hirano, Yasushi Higashiuesato

  • 1Department of Molecular Pathogenesis, Tokyo Medical and Dental University, Tokyo, Japan.

Journal of Human Genetics
|January 24, 2009
PubMed

Insights

The HCN4 channel, crucial for heart rate, may prevent bradycardia-induced ventricular arrhythmias. Mutations in HCN4 are linked to heart rhythm disorders, but its normal function appears protective.

Area of Science:

  • Cardiac Electrophysiology
  • Molecular Cardiology
  • Computational Biology

Background:

  • Bradycardia (slow heart rate) is a known trigger for ventricular arrhythmias, particularly in conditions like Brugada syndrome and long QT syndrome.
  • The HCN4 channel is a key regulator of heart rate, and its dysfunction is associated with inherited arrhythmias and bradycardia.
  • A patient with idiopathic ventricular tachycardia was found to have a genetic mutation in the HCN4 gene, predicted to result in a truncated channel.

Purpose of the Study:

  • To investigate the role of the HCN4 channel in the context of ventricular arrhythmias.
  • To explore the electrophysiological effects of HCN4 channel function during bradycardia.

Main Methods:

  • A genetic analysis identified a 4 base-insertion mutation in the HCN4 gene splice donor site in a patient with idiopathic ventricular tachycardia.
  • A computer simulation model was used to introduce the ventricular action potential of the I(f) current produced by HCN4.
  • The model analyzed the behavior of the I(f) current during the plateau phase of the ventricular action potential.

Main Results:

  • The I(f) current generated by the HCN4 channel exhibited a leaky outward current during the ventricular action potential plateau phase.
  • These HCN4 channel currents were computationally shown to shorten action potential duration.
  • The currents also appeared to prevent early after-depolarizations, a precursor to arrhythmias, during bradycardia.

Conclusions:

  • The HCN4 channel's normal function, through the I(f) current, may play a protective role against bradycardia-induced ventricular arrhythmias.
  • This suggests a potential dual role for HCN4: mutations leading to disease, but normal function being cardioprotective in specific contexts.
  • Further research into HCN4 channel function could reveal new therapeutic targets for managing cardiac arrhythmias.

Related Concept Videos

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...